Form 4: VirnetX Director Exercises Stock Options

VirnetX Holding Corp. Director Thomas M. O'Brien exercised options to acquire 625 shares of common stock at $10.104 per share.

Summary

• Thomas M. O'Brien, a Director of VirnetX Holding Corp. (VHC), reported a transaction on December 3, 2025.
• The transaction involved the exercise of a stock option to acquire 625 shares of VirnetX common stock.
• The exercise price for these shares was $10.104 per share.
• Following this transaction, O'Brien directly beneficially owns 27,957 shares of common stock.
• The stock option was fully vested and exercisable, with an expiration date of June 15, 2033.
• The reported share amounts reflect the Issuer's 1-for-20 reverse stock split, which was effective on October 25, 2023.

Sentiment

Score: 6

Explanation: Slightly positive, as a director exercising options to acquire shares can be interpreted as a minor signal of confidence in the company, although the transaction size is small.

Positives

• A director exercising stock options to acquire shares can signal confidence in the company's future prospects.
• The shares acquired were from fully vested options, indicating a planned or expected transaction.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction report (Form 4) detailing a director's exercise of stock options. It does not provide information related to broader industry trends or competitive landscape, but rather reflects an individual's activity within the company's equity structure.

Stakeholder Impact

• Shareholders: A minor increase in outstanding shares due to option exercise, but potentially a positive signal of insider confidence.
• Employees: No direct impact mentioned.

Key Dates

Keywords

VirnetX, VHC, Insider Transaction, Stock Option Exercise, Director, Beneficial Ownership, SEC Form 4